{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:15:50Z","timestamp":1794737750724,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA14051"],"award-info":[{"award-number":["P30-CA14051"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30-ES002109"],"award-info":[{"award-number":["P30-ES002109"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Mater."],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41563-021-01042-y","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T12:03:24Z","timestamp":1626350604000},"page":"1440-1448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Microenvironment-triggered multimodal precision diagnostics"],"prefix":"10.1038","volume":"20","author":[{"given":"Liangliang","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Rohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee T.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia M.","family":"Pulver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1007-2801","authenticated-orcid":false,"given":"Olivia J.","family":"Kelada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5286-3794","authenticated-orcid":false,"given":"Heather E.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank B.","family":"Gertler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1293-2097","authenticated-orcid":false,"given":"Sangeeta N.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"1042_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrclinonc.2016.171","volume":"14","author":"CJ Punt","year":"2017","unstructured":"Punt, C. J., Koopman, M. & Vermeulen, L. From tumour heterogeneity to advances in precision treatment of colorectal cancer. Nat. Rev. Clin. Oncol. 14, 235\u2013246 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1042_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nrclinonc.2014.90","volume":"11","author":"AK Siriwardena","year":"2014","unstructured":"Siriwardena, A. K., Mason, J. M., Mullamitha, S., Hancock, H. C. & Jegatheeswaran, S. Management of colorectal cancer presenting with synchronous liver metastases. Nat. Rev. Clin. Oncol. 11, 446\u2013459 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1042_CR3","doi-asserted-by":"publisher","first-page":"eabb9601","DOI":"10.1126\/science.abb9601","volume":"369","author":"AM Lennon","year":"2020","unstructured":"Lennon, A. M. et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science 369, eabb9601 (2020).","journal-title":"Science"},{"key":"1042_CR4","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1001\/jama.2012.5521","volume":"307","author":"PB Bach","year":"2012","unstructured":"Bach, P. B. et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307, 2418\u20132429 (2012).","journal-title":"JAMA"},{"key":"1042_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41586-020-2140-0","volume":"580","author":"JJ Chabon","year":"2020","unstructured":"Chabon, J. J. et al. Integrating genomic features for non-invasive early lung cancer detection. Nature 580, 245\u2013251 (2020).","journal-title":"Nature"},{"key":"1042_CR6","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen, J. D. et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359, 926\u2013930 (2018).","journal-title":"Science"},{"key":"1042_CR7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","volume":"31","author":"MC Liu","year":"2020","unstructured":"Liu, M. C. et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 31, 745\u2013759 (2020).","journal-title":"Ann. Oncol."},{"key":"1042_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41587-019-0064-8","volume":"37","author":"A Aalipour","year":"2019","unstructured":"Aalipour, A. et al. Engineered immune cells as highly sensitive cancer diagnostics. Nat. Biotechnol. 37, 531\u2013539 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1042_CR9","doi-asserted-by":"publisher","first-page":"eaaw0262","DOI":"10.1126\/scitranslmed.aaw0262","volume":"12","author":"JD Kirkpatrick","year":"2020","unstructured":"Kirkpatrick, J. D. et al. Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling. Sci. Transl. Med. 12, eaaw0262 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1042_CR10","doi-asserted-by":"publisher","first-page":"dmm036863","DOI":"10.1242\/dmm.036863","volume":"12","author":"CP Rakhit","year":"2019","unstructured":"Rakhit, C. P. et al. Early detection of pre-malignant lesions in a KRAS(G12D)-driven mouse lung cancer model by monitoring circulating free DNA. Dis. Model Mech. 12, dmm036863 (2019).","journal-title":"Dis. Model Mech."},{"key":"1042_CR11","doi-asserted-by":"publisher","first-page":"109ra116","DOI":"10.1126\/scitranslmed.3003110","volume":"3","author":"SS Hori","year":"2011","unstructured":"Hori, S. S. & Gambhir, S. S. Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations. Sci. Transl. Med. 3, 109ra116 (2011).","journal-title":"Sci. Transl. Med."},{"key":"1042_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrclinonc.2016.199","volume":"14","author":"EP van der Stok","year":"2017","unstructured":"van der Stok, E. P., Spaander, M. C. W., Grunhagen, D. J., Verhoef, C. & Kuipers, E. J. Surveillance after curative treatment for colorectal cancer. Nat. Rev. Clin. Oncol. 14, 297\u2013315 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1042_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/bjc.2014.351","volume":"111","author":"FL Rojas Llimpe","year":"2014","unstructured":"Rojas Llimpe, F. L. et al. Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study. Br. J. Cancer 111, 667\u2013673 (2014).","journal-title":"Br. J. Cancer"},{"key":"1042_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/7933","volume":"17","author":"R Weissleder","year":"1999","unstructured":"Weissleder, R., Tung, C. H., Mahmood, U. & Bogdanov, A. Jr In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375\u2013378 (1999).","journal-title":"Nat. Biotechnol."},{"key":"1042_CR15","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1073\/pnas.1414156112","volume":"112","author":"JA Ronald","year":"2015","unstructured":"Ronald, J. A., Chuang, H. Y., Dragulescu-Andrasi, A., Hori, S. S. & Gambhir, S. S. Detecting cancers through tumor-activatable minicircles that lead to a detectable blood biomarker. Proc. Natl Acad. Sci. USA 112, 3068\u20133073 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1042_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nbt.2464","volume":"31","author":"GA Kwong","year":"2013","unstructured":"Kwong, G. A. et al. Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nat. Biotechnol. 31, 63\u201370 (2013).","journal-title":"Nat. Biotechnol."},{"key":"1042_CR17","doi-asserted-by":"publisher","first-page":"0054","DOI":"10.1038\/s41551-017-0054","volume":"1","author":"EJ Kwon","year":"2017","unstructured":"Kwon, E. J., Dudani, J. S. & Bhatia, S. N. Ultrasensitive tumour-penetrating nanosensors of protease activity. Nat. Biomed. Eng. 1, 0054 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"1042_CR18","doi-asserted-by":"publisher","first-page":"8954","DOI":"10.1073\/pnas.1805337115","volume":"115","author":"JS Dudani","year":"2018","unstructured":"Dudani, J. S., Ibrahim, M., Kirkpatrick, J., Warren, A. D. & Bhatia, S. N. Classification of prostate cancer using a protease activity nanosensor library. Proc. Natl Acad. Sci. USA 115, 8954\u20138959 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1042_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrc3110","volume":"11","author":"BA Webb","year":"2011","unstructured":"Webb, B. A., Chimenti, M., Jacobson, M. P. & Barber, D. L. Dysregulated pH: a perfect storm for cancer progression. Nat. Rev. Cancer 11, 671\u2013677 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"1042_CR20","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423\u20131437 (2013).","journal-title":"Nat. Med."},{"key":"1042_CR21","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"1042_CR22","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nrclinonc.2015.129","volume":"12","author":"C Cremolini","year":"2015","unstructured":"Cremolini, C. et al. First-line chemotherapy for mCRC\u2014a review and evidence-based algorithm. Nat. Rev. Clin. Oncol. 12, 607\u2013619 (2015).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1042_CR23","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.1073\/pnas.1303708110","volume":"110","author":"D Weerakkody","year":"2013","unstructured":"Weerakkody, D. et al. Family of pH (low) insertion peptides for tumor targeting. Proc. Natl Acad. Sci. USA 110, 5834\u20135839 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1042_CR24","doi-asserted-by":"publisher","first-page":"E2811","DOI":"10.1073\/pnas.1715350115","volume":"115","author":"LC Wyatt","year":"2018","unstructured":"Wyatt, L. C. et al. Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors. Proc. Natl Acad. Sci. USA 115, E2811\u2013E2818 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1042_CR25","doi-asserted-by":"publisher","first-page":"289ra284","DOI":"10.1126\/scitranslmed.aaa3519","volume":"7","author":"T Danino","year":"2015","unstructured":"Danino, T. et al. Programmable probiotics for detection of cancer in urine. Sci. Transl. Med. 7, 289ra284 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1042_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4161\/cbt.10.2.12163","volume":"10","author":"CD Dumitru","year":"2010","unstructured":"Dumitru, C. D., Antonysamy, M. A., Tomai, M. A. & Lipson, K. E. Potentiation of the anti-tumor effects of imidazoquinoline immune response modifiers by cyclophosphamide. Cancer Biol. Ther. 10, 155\u2013165 (2010).","journal-title":"Cancer Biol. Ther."},{"key":"1042_CR27","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1158\/0008-5472.CAN-12-2796","volume":"73","author":"V Estrella","year":"2013","unstructured":"Estrella, V. et al. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 73, 1524\u20131535 (2013).","journal-title":"Cancer Res."},{"key":"1042_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","volume":"17","author":"C Corbet","year":"2017","unstructured":"Corbet, C. & Feron, O. Tumour acidosis: from the passenger to the driver\u2019s seat. Nat. Rev. Cancer 17, 577\u2013593 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"1042_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","volume":"20","author":"A Kalbasi","year":"2019","unstructured":"Kalbasi, A. & Ribas, A. Tumour-intrinsic resistance to immune checkpoint blockade. Nat. Rev. Immunol. 20, 25\u201339 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1042_CR30","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan, C., Van Schaeybroeck, S., Longley, D. B. & Johnston, P. G. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 13, 714\u2013726 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"1042_CR31","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1158\/0008-5472.CAN-18-1604","volume":"79","author":"N Rohani","year":"2019","unstructured":"Rohani, N. et al. Acidification of tumor at stromal boundaries drives transcriptome alterations associated with aggressive phenotypes. Cancer Res. 79, 1952\u20131966 (2019).","journal-title":"Cancer Res."},{"key":"1042_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9752","volume":"6","author":"M Damaghi","year":"2015","unstructured":"Damaghi, M. et al. Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane. Nat. Commun. 6, 8752 (2015).","journal-title":"Nat. Commun."},{"key":"1042_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10555-007-9064-0","volume":"26","author":"P Swietach","year":"2007","unstructured":"Swietach, P., Vaughan-Jones, R. D. & Harris, A. L. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev. 26, 299\u2013310 (2007).","journal-title":"Cancer Metastasis Rev."},{"key":"1042_CR34","doi-asserted-by":"publisher","first-page":"20150431","DOI":"10.1259\/bjr.20150431","volume":"89","author":"S Kumar","year":"2016","unstructured":"Kumar, S. et al. Magnetic resonance imaging in lung: a review of its potential for radiotherapy. Br. J. Radiol. 89, 20150431 (2016).","journal-title":"Br. J. Radiol."},{"key":"1042_CR35","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.1158\/0008-5472.CAN-16-0825","volume":"76","author":"DL Longo","year":"2016","unstructured":"Longo, D. L. et al. In vivo imaging of tumor metabolism and acidosis by combining PET and MRI-CEST pH imaging. Cancer Res. 76, 6463\u20136470 (2016).","journal-title":"Cancer Res."},{"key":"1042_CR36","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nbt1217-1211a","volume":"35","author":"J Roper","year":"2017","unstructured":"Roper, J. et al. Corrigendum: in vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat. Biotechnol. 35, 1211 (2017).","journal-title":"Nat. Biotechnol."},{"key":"1042_CR37","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nm.3252","volume":"19","author":"S Walker-Samuel","year":"2013","unstructured":"Walker-Samuel, S. et al. In vivo imaging of glucose uptake and metabolism in tumors. Nat. Med. 19, 1067\u20131072 (2013).","journal-title":"Nat. Med."},{"key":"1042_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","volume":"69","author":"J Chiche","year":"2009","unstructured":"Chiche, J. et al. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 69, 358\u2013368 (2009).","journal-title":"Cancer Res."},{"key":"1042_CR39","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41563-019-0503-4","volume":"18","author":"Y Yuan","year":"2019","unstructured":"Yuan, Y. et al. Furin-mediated intracellular self-assembly of olsalazine nanoparticles for enhanced magnetic resonance imaging and tumour therapy. Nat. Mater. 18, 1376\u20131383 (2019).","journal-title":"Nat. Mater."},{"key":"1042_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49514-1","volume":"9","author":"LR Lindeman","year":"2019","unstructured":"Lindeman, L. R. et al. Differentiating lung cancer and infection based on measurements of extracellular pH with acidoCEST MRI. Sci. Rep. 9, 13002 (2019).","journal-title":"Sci. Rep."},{"key":"1042_CR41","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/adma.200800004","volume":"20","author":"JH Park","year":"2008","unstructured":"Park, J. H. et al. Magnetic iron oxide nanoworms for tumor targeting and imaging. Adv. Mater. 20, 1630\u20131635 (2008).","journal-title":"Adv. Mater."},{"key":"1042_CR42","doi-asserted-by":"publisher","first-page":"14181","DOI":"10.1073\/pnas.1817442116","volume":"116","author":"N Jailkhani","year":"2019","unstructured":"Jailkhani, N. et al. Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix. Proc. Natl Acad. Sci. USA 116, 14181\u201314190 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1042_CR43","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1158\/0008-5472.CAN-16-3346","volume":"77","author":"BM Larimer","year":"2017","unstructured":"Larimer, B. M. et al. Granzyme B PET imaging as a predictive biomarker of immunotherapy response. Cancer Res. 77, 2318\u20132327 (2017).","journal-title":"Cancer Res."},{"key":"1042_CR44","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41551-019-0416-1","volume":"4","author":"G Huang","year":"2020","unstructured":"Huang, G. et al. PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers. Nat. Biomed. Eng. 4, 314\u2013324 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"1042_CR45","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tibtech.2017.03.014","volume":"35","author":"LC Wyatt","year":"2017","unstructured":"Wyatt, L. C., Lewis, J. S., Andreev, O. A., Reshetnyak, Y. K. & Engelman, D. M. Applications of pHLIP technology for cancer imaging and therapy. Trends Biotechnol. 35, 653\u2013664 (2017).","journal-title":"Trends Biotechnol."},{"key":"1042_CR46","doi-asserted-by":"publisher","first-page":"7254","DOI":"10.1073\/pnas.1405240111","volume":"111","author":"NT Viola-Villegas","year":"2014","unstructured":"Viola-Villegas, N. T. et al. Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer. Proc. Natl Acad. Sci. USA 111, 7254\u20137259 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1042_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1096\/fj.201800019RR","volume":"33","author":"J Chang","year":"2019","unstructured":"Chang, J. et al. Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin. FASEB J. 33, 114\u2013125 (2019).","journal-title":"FASEB J."},{"key":"1042_CR48","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1073\/pnas.1314651111","volume":"111","author":"AD Warren","year":"2014","unstructured":"Warren, A. D., Kwong, G. A., Wood, D. K., Lin, K. Y. & Bhatia, S. N. Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics. Proc. Natl Acad. Sci. USA 111, 3671\u20133676 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1042_CR49","unstructured":"Bhatia, S. N. et al. Sensors for detecting and imaging of cancer metastasis. US Patent Application No. 16\/745,748 (2020)."}],"container-title":["Nature Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41563-021-01042-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-021-01042-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-021-01042-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T14:41:31Z","timestamp":1657118491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41563-021-01042-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1042"],"URL":"https:\/\/doi.org\/10.1038\/s41563-021-01042-y","relation":{},"ISSN":["1476-1122","1476-4660"],"issn-type":[{"value":"1476-1122","type":"print"},{"value":"1476-4660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"6 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.N.B. and L.H. are listed as inventors on a patent application<sup>49<\/sup> related to the content of this work. S.N.B. holds equity in Glympse Bio, Satellite Bio, Cend Therapeutics and Catalio Capital; is a director at Vertex; consults for Moderna, and receives sponsored research funding from Johnson & Johnson. All the other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}